HCA Healthcare Inc (NYSE:HCA) insider Michael S. Cuffe sold 4,943 shares of the firm’s stock in a transaction dated Friday, November 9th. The stock was sold at an average price of $141.90, for a total value of $701,411.70. Following the sale, the insider now directly owns 33,240 shares in the company, valued at approximately $4,716,756. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Michael S. Cuffe also recently made the following trade(s):

  • On Friday, November 2nd, Michael S. Cuffe sold 5,196 shares of HCA Healthcare stock. The stock was sold at an average price of $136.52, for a total value of $709,357.92.

Shares of NYSE:HCA traded up $2.32 during mid-day trading on Friday, reaching $143.95. 1,903,245 shares of the stock were exchanged, compared to its average volume of 2,252,907. The company has a market cap of $48.75 billion, a PE ratio of 21.84, a PEG ratio of 1.24 and a beta of 0.48. HCA Healthcare Inc has a one year low of $74.26 and a one year high of $144.18.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.23. The business had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. HCA Healthcare’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period last year, the company earned $1.13 earnings per share. On average, research analysts anticipate that HCA Healthcare Inc will post 9.35 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be issued a dividend of $0.35 per share. The ex-dividend date is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.97%. HCA Healthcare’s payout ratio is presently 21.24%.

HCA has been the topic of a number of research analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and set a $135.00 price target on shares of HCA Healthcare in a research report on Thursday, July 26th. SunTrust Banks raised their price target on HCA Healthcare to $145.00 and gave the stock a “buy” rating in a research report on Thursday, July 26th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $115.00 price target on shares of HCA Healthcare in a research report on Friday, July 20th. ValuEngine raised HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Wednesday, July 18th. Finally, Zacks Investment Research raised HCA Healthcare from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a research report on Monday, July 16th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $141.53.

Several large investors have recently bought and sold shares of HCA. FMR LLC grew its holdings in shares of HCA Healthcare by 98.7% during the third quarter. FMR LLC now owns 10,907,407 shares of the company’s stock worth $1,517,438,000 after buying an additional 5,419,134 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of HCA Healthcare by 98.3% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,767,715 shares of the company’s stock worth $245,925,000 after buying an additional 876,226 shares in the last quarter. Renaissance Technologies LLC grew its holdings in shares of HCA Healthcare by 187.9% during the second quarter. Renaissance Technologies LLC now owns 1,094,431 shares of the company’s stock worth $112,289,000 after buying an additional 714,331 shares in the last quarter. LSV Asset Management grew its holdings in shares of HCA Healthcare by 9.2% during the second quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock worth $560,133,000 after buying an additional 457,752 shares in the last quarter. Finally, Acadian Asset Management LLC grew its holdings in shares of HCA Healthcare by 213.7% during the third quarter. Acadian Asset Management LLC now owns 645,679 shares of the company’s stock worth $89,830,000 after buying an additional 439,826 shares in the last quarter. Institutional investors and hedge funds own 70.84% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “HCA Healthcare Inc (HCA) Insider Michael S. Cuffe Sells 4,943 Shares” was first posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://www.dailypolitical.com/2018/11/10/hca-healthcare-inc-hca-insider-michael-s-cuffe-sells-4943-shares.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: Return on Equity (ROE)

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.